Nexalin $NXL: Breakthrough in Alzheimer’s Treatment Millions face the growing challenge of Alzheimer’s, and Nexalin is changing the treatment paradigm. $NXL recently announced peer-reviewed results showing its patented Deep Intracranial Frequency Stimulation (DIFS™) technology improved cognitive performance and enhanced brain connectivity in patients with mild Alzheimer’s disease, as published in Radiology. Watch our 30-Second Overview: https://t.co/QjXv9ufmrt $NXL $VRTX $STIM $NMTC $LLY $AMGN $REGN $GILD $MRNA
RedChipShare
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.